PrimePac® PRRS

PrimePac® PRRS is a live attenuated vaccine developed to help control Porcine Reproductive and Respiratory Syndrome (PRRS), also known as Blue-Ear Disease, in pigs. The vaccine helps reduce clinical signs, limit viral shedding, and support protection against highly virulent PRRS virus strains.

Composition

• Live attenuated PRRS antigen: Minnesota 4.0 strain (4.0 log10).

• Adjuvant: Diluvac Forte.

Indications

PrimePac® PRRS is intended to help:

• Prevent PRRS in healthy pigs.

• Reduce clinical signs and minimize losses associated with the disease.

• Limit PRRS virus replication and shedding within the herd.

• Provide cross-protection against certain highly virulent PRRS virus strains, including variant strains, as supported by the manufacturer's data.

Key Benefits of PrimePac® PRRS

• Safe, flexible, and effective
  Suitable for different groups of pigs when used according to the manufacturer's instructions.

• Helps reduce clinical signs
  Helps limit fever, respiratory problems, and reproductive disorders associated with PRRS.

• Helps reduce PRRS virus shedding
  Supports disease control and helps reduce the risk of transmission within the herd.

• Cross-protection
  Designed to stimulate an immune response against multiple PRRS virus strains, including certain highly virulent strains, subject to the vaccine's demonstrated efficacy.

Dosage and Administration

• Dosage: 0.2 ml per animal.

• Routes of administration:

  • Intradermal (ID): Using the IDAL system.

  • Intramuscular (IM): Injection into the muscle.

Recommended Vaccination Schedule

1. Piglets

• Single dose: At 2 weeks of age.

2. Sows and Replacement Gilts

• One dose: Repeat every 4 months.

Packaging

• 50-dose vial

• 100-dose vial